Lysins Unlimited: Phages’ Secret Weapon
Spirulina platform Lumen large as firm bags series A, therapies and more ahead
Read More
Seattle biotech startup Lumen Bioscience raises $11.2M to develop drugs using algae
The financing allows Lumen Bioscience to continue developing technology that uses the algae spirulina to make biologics. Read More
Fred Hutch and Adaptive Biotechnologies vets raise $13M for biotech startup
Lumen is chasing the $1.5 billion market for natural colorants with technology that uses Spirulina.Recent Post
4 ideas to kick-start U.S. drug research — and beat China in biotech
Revolutionizing the Production of Biologics with Algae
Past Wilkes Prize winners accelerate audacious climate solutions
Reviewing Real-World Safety and Efficacy Data on C difficile Therapy Rebyota- Contagion Live Article on RePreve Trial